EUVIMEDEUVIMED entdecken
Crossref

Genome-sequencing-based benchmarking of antimicrobial resistance, treatment outcomes and healthcare transmission events for Clostridioides difficile infection in Australian hospitals

Annalise Unsworth, Winkie Fong, Fanrong Kong, Qinning Wang, Jignasa Purani, Jen Kok, Sharon C-A Chen, Vitali Sintchenko

Journal of Hospital Infection · 2026

DOI: 10.1016/j.jhin.2026.07.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hospital Infection, 2026. Verfasst von Annalise Unsworth und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Sydney, New South Wales, Australia. Electronic address: annal…. Hauptthemen laut MEDLINE: Clostridioides difficile, Cross Infection, Clostridium Infections, Anti-Bacterial Agents. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clostridioides difficile infection (CDI) remains a priority for infection prevention and control in health care, particularly with the emergence of hypervirulent strains and antimicrobial resistance (AMR). AIM: To characterize the genomic epidemiology and AMR profiles of culture-confirmed CDI cases within tertiary hospitals in Australia. METHODS: A total of 155 C. difficile isolates from 142 patients with CDI diagnosed in four hospitals between 2023 and 2025 were studied. Data collected included patient demographics, severity of infection, antibiotic treatment and clinical outcomes at 8 weeks. Phenotypic susceptibility to vancomycin, fidaxomicin, metronidazole, moxifloxacin, meropenem, tetracycline and rifaximin were determined by agar dilution. Isolates underwent whole-genome sequencing (WGS) for genotyping and resistome assessment. FINDINGS: WGS differentiated 39 distinct sequence types among CDI isolates across different healthcare services. In total, 100 isolates were singletons and 55 (35% clustering rate) isolates were considered to be genomically related (difference of two or fewer single-nucleotide polymorphisms). Of these, 12 patients (8.5%) with close hospital contact formed six epidemiologically linked clusters. Phenotypic susceptibility results were obtained for 134 (86.4%) CDI isolates. There was no phenotypic resistance to vancomycin [minimum inhibitory concentration required to inhibit the growth of 90% of isolates (MIC90) 1 mg/L], metronidazole (MIC90 0.5 mg/L) or fidaxomicin (MIC90 0.5 mg/L). There was no association in the study cohort between the presence of resistance genes or reduced phenotypic susceptibility and CDI recurrence. CONCLUSION: Genomic analysis of C. difficile isolates did not identify any outbreaks or an association between the sequence type or presence of a resistance gene and clinical outcomes. High-resolution characterization and identification of antibiotic resistance, CDI clinical relapse and recent transmission offered by genome sequencing can provide important benchmarks for hospital infection control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileCross InfectionClostridium InfectionsAnti-Bacterial AgentsDrug Resistance, BacterialBenchmarkingHumansAustraliaWhole Genome SequencingFemaleAgedMaleTreatment OutcomeMicrobial Sensitivity TestsAged, 80 and overMiddle AgedGenotypeTertiary Care CentersAdult

Stichwörter der Autor:innen

Antibiotic resistanceCDI epidemiologyClostridioides difficileGenomic surveillanceHospital-associated infectionsTreatment outcomes

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Sydney, New South Wales, Australia. Electronic address: annalise.unsworth@health.nsw.gov.au.
  • Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Sydney, New South Wales, Australia; School of Medical Sciences and Sydney Infectious Diseases Institute, Faculty of Medicine and Health…
  • Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Sydney, New South Wales, Australia.
  • Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Sydney, New South Wales, Australia; Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Sydney, New…

Zitieren

APA

Unsworth, A., Fong, W., Kong, F., Wang, Q., Purani, J., Kok, J., Chen, S. C., & Sintchenko, V. (2026). Genome-sequencing-based benchmarking of antimicrobial resistance, treatment outcomes and healthcare transmission events for Clostridioides difficile infection in Australian hospitals. Journal of Hospital Infection. https://doi.org/10.1016/j.jhin.2026.07.021

Vancouver

Unsworth A, Fong W, Kong F, Wang Q, Purani J, Kok J, et al. Genome-sequencing-based benchmarking of antimicrobial resistance, treatment outcomes and healthcare transmission events for Clostridioides difficile infection in Australian hospitals. Journal of Hospital Infection. 2026. doi:10.1016/j.jhin.2026.07.021

BibTeX
@article{Unsworth2026,
  author = {Unsworth, Annalise and Fong, Winkie and Kong, Fanrong and Wang, Qinning and Purani, Jignasa and Kok, Jen and Chen, Sharon C-A and Sintchenko, Vitali},
  title = {Genome-sequencing-based benchmarking of antimicrobial resistance, treatment outcomes and healthcare transmission events for Clostridioides difficile infection in Australian hospitals},
  journal = {Journal of Hospital Infection},
  year = {2026},
  doi = {10.1016/j.jhin.2026.07.021}
}
Kostenlos starten →